Kalshi to Offer Betting on Clinical Trial and FDA Drug Decisions
Kalshi, a prediction market platform, is expanding its offerings to allow users to bet on the outcomes of clinical trials and FDA drug approval decisions. This move introduces a new form of financial speculation into the pharmaceutical and healthcare sectors.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Kalshi to offer betting on drug trial results and FDA regulatory decisions
Move comes as prediction platforms rapidly gain popularity and offer opportunities to bet on virtually anything Kalshi is expanding its wagers to include bets on drug trial results and is considering offering contracts on flight delays, as prediction market platforms continue to rapidly gain popularity and offer opportunities to bet on virtually anything. The betting platform said the expansion into clinical trials and FDA regulatory decisions will help surface information on drug trials that...
By Gaya Gupta
Read full article →Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions - Forbes
Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions Forbes
Read full article →
